Back to search

Germany· DE-A57-b7a08da45e0ab4cd

Ramipril/Bisoprolol Egis

A medicinal product containing bisoprolol fumarate, ramipril, registered in Germany by Egis Pharmaceuticals Plc.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedRamipril/Bisoprolol EgisATC—REGISTER NO.DE-A57-b7a08da45e0ab4…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Active substance
Bisoprolol Fumarate, Ramipril
Manufacturer
Egis Pharmaceuticals Plc
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bisoprolol fumarate, ramipril in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bisoprolol fumarate, ramipril products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Ralanbi, Rambofort
  • Bulgaria · Вивейс Плюс, Калиса
  • Cyprus · Proramace
  • Czechia · Ralbior
  • Estonia · Bisramex
  • Spain · Rabidux, Ramipril/Bisoprolol Egis
  • Greece · Proramace
  • Croatia · Byol Combi, Ramipril/Bisoprololfumarat Elc
  • Hungary · Diptensa, Ramipril/Bisoprolol
  • Italy · Rabisop, Ramilolo
  • Lithuania · Bisramex
  • Latvia · Bisramex
  • Poland · Acebis, Ladinorm
  • Portugal · Rabidux, Ramipril + Bisoprolol Egis
  • Slovakia · Ralbior

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dc583917-25b6-4bfd-a22d-7fad114e31a4
GET /v1/drugs/dc583917-25b6-4bfd-a22d-7fad114e31a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Bisoprolol Fumarate, Ramipril",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about bisoprolol fumarate, ramipril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.